Detalhe da pesquisa
1.
Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells.
Int J Mol Sci
; 24(6)2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982651
2.
The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines.
Int J Mol Sci
; 23(21)2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362189
3.
New Acetophenones and Chromenes from the Leaves of Melicope barbigera A. Gray.
Molecules
; 26(3)2021 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33525713
4.
Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response.
Blood
; 132(3): 307-320, 2018 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724897
5.
Novel alkoxyamide-based histone deacetylase inhibitors reverse cisplatin resistance in chemoresistant cancer cells.
Bioorg Med Chem
; 28(1): 115108, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787463
6.
Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors.
Int J Mol Sci
; 21(21)2020 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33167494
7.
In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi).
Int J Mol Sci
; 21(13)2020 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32635356
8.
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs).
Angew Chem Int Ed Engl
; 59(50): 22494-22499, 2020 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780485
9.
Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension.
J Cell Mol Med
; 23(4): 2801-2812, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734467
10.
3-O-Methyl-Alkylgallates Inhibit Fatty Acid Desaturation in Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 63(9)2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209015
11.
Profiling of a suramin-derived compound library at recombinant human P2Y receptors identifies NF272 as a competitive but non-selective P2Y2 receptor antagonist.
Purinergic Signal
; 15(3): 287-298, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31270713
12.
Recent advances in class IIa histone deacetylases research.
Bioorg Med Chem
; 27(22): 115087, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31561937
13.
The tetrahydroxanthone-dimer phomoxanthone A is a strong inducer of apoptosis in cisplatin-resistant solid cancer cells.
Bioorg Med Chem
; 27(19): 115044, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31443950
14.
Novel α,ß-unsaturated hydroxamic acid derivatives overcome cisplatin resistance.
Bioorg Med Chem
; 27(19): 115036, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431326
15.
Cyclic heptapeptides from the soil-derived fungus Clonostachys rosea.
Bioorg Med Chem
; 27(17): 3954-3959, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31324567
16.
Indole Diterpenoids from an Endophytic Penicillium sp.
J Nat Prod
; 82(6): 1412-1423, 2019 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31117519
17.
Brominated Azaphilones from the Sponge-Associated Fungus Penicillium canescens Strain 4.14.6a.
J Nat Prod
; 82(8): 2159-2166, 2019 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31359750
18.
Cryptic Secondary Metabolites from the Sponge-Associated Fungus Aspergillus ochraceus.
Mar Drugs
; 17(2)2019 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30717441
19.
Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.
Int J Mol Sci
; 20(12)2019 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234549
20.
Adenosine enhances cisplatin sensitivity in human ovarian cancer cells.
Purinergic Signal
; 14(4): 395-408, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30078088